Bonus Biogroup (BBIXF) Stock Statistics & Valuation Metrics
Total Valuation
Bonus Biogroup has a market cap or net worth of $65.75M. The enterprise value is $380.97T.
- Market Cap
- $65.75M
- Enterprise Value
- $380.97T
Share Statistics
Bonus Biogroup has 1,168,135,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,168,135,300
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Bonus Biogroup’s return on equity (ROE) is 4.32 and return on invested capital (ROIC) is -699.94%.
- Return on Equity (ROE)
- 4.32
- Return on Assets (ROA)
- -1.59
- Return on Invested Capital (ROIC)
- -699.94%
- Return on Capital Employed (ROCE)
- -15.64
- Revenue Per Employee
- 0
- Profits Per Employee
- -583.10K
- Employee Count
- 42
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Bonus Biogroup is -17.65. Bonus Biogroup’s PEG ratio is -0.32.
- PE Ratio
- -17.65
- PS Ratio
- 0.00
- PB Ratio
- -24.79
- Price to FCF
- -13.88
- Price to Operating Cash Flow
- -13.91
- PEG Ratio
- -0.32
Income Statement
In the last 12 months, Bonus Biogroup had revenue of 0 and earned -24.49M in profits. Earnings per share was -0.04.
- Revenue
- 0
- Gross Profit
- -2.76M
- Operating Income
- -22.64M
- Pretax Income
- -24.49M
- Net Income
- -24.49M
- EBITDA
- -19.88M
- Earnings Per Share (EPS)
- -0.04
Cash Flow
In the last 12 months, operating cash flow was -15.11M and capital expenditures -38,000, giving a free cash flow of -15.15M billion.
- Operating Cash Flow
- -15.11M
- Free Cash Flow
- -15.15M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Bonus Biogroup pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -7.37%
- Earnings Yield
- -11.61%
Stock Price Statistics
- Beta
- -54.73
- 52-Week Price Change
- -50.00%
- 50-Day Moving Average
- 0.04
- 200-Day Moving Average
- 0.09
- Relative Strength Index (RSI)
- 36.95
- Average Volume (3m)
- 2,293
Financial Position
Bonus Biogroup as a current ratio of 0.13, with Debt / Equity ratio of -157.10%
- Current Ratio
- 0.13
- Quick Ratio
- 0.13
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -0.44
- Interest Coverage Ratio
- -32.20
Taxes
In the past 12 months, Bonus Biogroup has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Bonus Biogroup EV to EBITDA ratio is -10.48, with an EV/FCF ratio of -14.08.
- EV to Sales
- 0.00
- EV to EBITDA
- -10.48
- EV to Free Cash Flow
- -14.08
- EV to Operating Cash Flow
- -14.12
Balance Sheet
Bonus Biogroup has $439.00K in cash and marketable securities with $8.18M in debt, giving a net cash position of -$7.74M billion.
- Cash & Marketable Securities
- $439.00K
- Total Debt
- $8.18M
- Net Cash
- -$7.74M
- Net Cash Per Share
- -$0.01
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Bonus Biogroup is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
